In support of this notion, RRShigh patients have significantly higher infiltration of immune cells with anti-tumor activity including activated CD4+ T cells, activated CD8+ T cells and immature B cells than RRSlow patients in TCGA cohort, as determined by ssGSEA analysis (Fig. 6a). Here, CD8A is linked to neoplasm.